Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer With Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00838929
What this trial is testing

Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases

Who this might be right for
Brain Metastases
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableLooking for participantsNCT06330870
What this trial is testing

Brain Metastasis Development Mechanism in BCBM Patients

Who this might be right for
Breast CancerBrain Metastasis
Samsung Medical Center 30
Post-approval studies (Phase 4)Looking for participantsNCT06072807
What this trial is testing

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04538742
What this trial is testing

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 245
Early research (Phase 1)Ended earlyNCT05553522
What this trial is testing

Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer

Who this might be right for
Brain MetastasesHER2-positive Breast Cancer
Baptist Health South Florida 1
Not applicableActive Not RecruitingNCT05703269
What this trial is testing

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Who this might be right for
NSCLCRenal Cell CarcinomaBreast Carcinoma+5 more
Wake Forest University Health Sciences 58
Early research (Phase 1)Study completedNCT00470847
What this trial is testing

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Nancy Lin, MD 35
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Testing effectiveness (Phase 2)Study completedNCT01332630
What this trial is testing

TPI 287 in Breast Cancer Metastatic to the Brain

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06418594
What this trial is testing

Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis

Who this might be right for
HER2-negative Breast Cancer Brain Metastases
Beijing 302 Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT00581113
What this trial is testing

Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases

Who this might be right for
Lung CancerBreast CancerProstate Cancer
Virginia Commonwealth University 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150208
What this trial is testing

T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis

Who this might be right for
Breast Cancer With Brain MetastasisHER2-low Expressing Breast Cancer
Fudan University 140
Not applicableLooking for participantsNCT07117864
What this trial is testing

Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer

Who this might be right for
Breast Cancer
QIAO LI 40
Not applicableNot Yet RecruitingNCT07689721
What this trial is testing

CtDNA-Guided Intraventricular Therapy for CNS Malignancies

Who this might be right for
Leptomeningeal DiseaseGlioblastomaBrain Metastases+2 more
Alireza Mansouri 77
Early research (Phase 1)Ended earlyNCT02598427
What this trial is testing

Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

Who this might be right for
HER2 Positive Untreated Metastatic Breast CancerAsymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer
Kimberly Blackwell 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06975462
What this trial is testing

A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

Who this might be right for
Breast Cancer Metastatic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT00083304
What this trial is testing

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

Who this might be right for
Breast CancerMetastases
Spectrum Pharmaceuticals, Inc 368
Testing effectiveness (Phase 2)Ended earlyNCT00538343
What this trial is testing

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

Who this might be right for
Brain Metastases
Biogen 14
Next Page